Key facts
- This page summarizes Beloo Mirakhur's Form 4 filing for Celularity Inc (CELU).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Sep 2021, 18:50.
Beloo Mirakhur - 13 Sep 2021 Form 4 Insider Report for Celularity Inc (CELU)
- Reporting relationship
- EVP, Clinical Development
- Issuer ticker
- CELU
- Reported as of
- 13 Sep 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Keary Dunn, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Beloo Mirakhur filed Form 4 for Celularity Inc (CELU) on 15 Sep 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CELU
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +125,000
- Change %
- Price
- $0.000000
- Shares after
- 125,000
- Date
- 13 Sep 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 125,000
- Exercise price
- $6.87
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.